106 related articles for article (PubMed ID: 12651235)
1. Expressions of latent membrane protein 1, p53 and bcl-2 proteins and their significance in Hodgkin's lymphoma.
Qi ZL; Zhao T; Zhou XH; Zhang JH; Han XQ; Zhu MG
Di Yi Jun Yi Da Xue Xue Bao; 2003 Mar; 23(3):225-7. PubMed ID: 12651235
[TBL] [Abstract][Full Text] [Related]
2. Expression of p53, p21/waf1, bcl-2, bax, Rb and Ki67 proteins in Hodgkin's lymphomas.
Kanavaros P; Stefanaki K; Vlachonikolis J; Eliopoulos G; Kakolyris S; Rontogianni D; Gorgoulis V; Georgoulias V
Histol Histopathol; 2000 Apr; 15(2):445-53. PubMed ID: 10809363
[TBL] [Abstract][Full Text] [Related]
3. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
[TBL] [Abstract][Full Text] [Related]
4. [Epstein-Barr virus infection and the expression of bcl-2 proto-oncogene in Hodgkin's disease].
Liu C; Liao S; Gao Z
Zhonghua Bing Li Xue Za Zhi; 1997 Jun; 26(3):155-7. PubMed ID: 10072857
[TBL] [Abstract][Full Text] [Related]
5. [Presence of bcl-2 and p53 proteins in patients with non-Hodgkin's lymphoma at Zadar General Hospital].
Skunca Z; Gverić-Krecak V; Dominis M; Planinc-Peraica A; Jaksić B
Acta Med Croatica; 2004; 58(3):183-6. PubMed ID: 15503680
[TBL] [Abstract][Full Text] [Related]
6. Molecular markers in gastric cancer: can p53 and bcl-2 protein expressions be used as prognostic factors?
Zafirellis K; Karameris A; Milingos N; Androulakis G
Anticancer Res; 2005; 25(5):3629-36. PubMed ID: 16101192
[TBL] [Abstract][Full Text] [Related]
7. Cooperative interactions among p53, bcl-2 and Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma cells.
Sheu LF; Chen A; Lee HS; Hsu HY; Yu DS
Pathol Int; 2004 Jul; 54(7):475-85. PubMed ID: 15189500
[TBL] [Abstract][Full Text] [Related]
8. Structural variability of the carboxy-terminus of Epstein-Barr virus encoded latent membrane protein 1 gene in Hodgkin's lymphomas.
Guiretti DM; Chabay PA; Valva P; Stefanoff CG; Barros MH; De Matteo E; Renault IZ; Preciado MV; Hassan R
J Med Virol; 2007 Nov; 79(11):1730-22. PubMed ID: 17854036
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr viral infection in extranodal lymphoma of the head and neck: correlation with prognosis and response to treatment.
Bahnassy AA; Zekri AR; Asaad N; El-Houssini S; Khalid HM; Sedky LM; Mokhtar NM
Histopathology; 2006 Apr; 48(5):516-28. PubMed ID: 16623777
[TBL] [Abstract][Full Text] [Related]
10. Large B-cell lymphoma with Hodgkin's features.
García JF; Mollejo M; Fraga M; Forteza J; Muniesa JA; Pérez-Guillermo M; Pérez-Seoane C; Rivera T; Ortega P; Piris MA
Histopathology; 2005 Jul; 47(1):101-10. PubMed ID: 15982329
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of Bax, Bcl-2, and p53 expressions in cervical squamous cell carcinoma treated by radiotherapy.
Wootipoom V; Lekhyananda N; Phungrassami T; Boonyaphiphat P; Thongsuksai P
Gynecol Oncol; 2004 Sep; 94(3):636-42. PubMed ID: 15350352
[TBL] [Abstract][Full Text] [Related]
12. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
[TBL] [Abstract][Full Text] [Related]
13. [Mummified Hodgkin and Reed-Sternberg cells in EBV positive and EBV negative Hodgkin's lymphomas, Bcl-2 positivity and evaluation of survival].
Macák J; Bertová M
Vnitr Lek; 2001 Mar; 47(3):151-5. PubMed ID: 15635876
[TBL] [Abstract][Full Text] [Related]
14. Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases.
Zettl A; Rüdiger T; Marx A; Müller-Hermelink HK; Ott G
Histopathology; 2005 Feb; 46(2):217-28. PubMed ID: 15693895
[TBL] [Abstract][Full Text] [Related]
15. [Molecular pathological characteristics of human B-cell lymphomas induced by Epstein-Barr virus].
Gan RL; Yin ZH; Liu TF; Dong BH; Zhou JG; Yao KT
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):925-9. PubMed ID: 14515211
[TBL] [Abstract][Full Text] [Related]
16. Expression of bcl-2 in classical Hodgkin's lymphoma: an independent predictor of poor outcome.
Sup SJ; Alemañy CA; Pohlman B; Elson P; Malhi S; Thakkar S; Steinle R; Hsi ED
J Clin Oncol; 2005 Jun; 23(16):3773-9. PubMed ID: 15809450
[TBL] [Abstract][Full Text] [Related]
17. [C-terminal 30 bp-deletion mutation of latent membrane protein 1 gene of Epstein-barr virus in non-hodgkin's lymphoma].
Liu JR; Lin Q; Wu XY
Ai Zheng; 2005 Feb; 24(2):145-8. PubMed ID: 15694022
[TBL] [Abstract][Full Text] [Related]
18. [bcl-2 and p53 protein expressions in the malignant transformation of ovarian endometriosis].
Qian J; Shi Y
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):403-5. PubMed ID: 11810773
[TBL] [Abstract][Full Text] [Related]
19. Oncogene expression in tumour cells of pediatric Hodgkin's disease in Argentina--correlation with Epstein Barr virus presence.
Preciado MV; Cristobal E; Menarguez J; Martinez Montero JC; Diez B; De Matteo E; Grinstein S
Pathol Res Pract; 1998; 194(1):25-31. PubMed ID: 9542744
[TBL] [Abstract][Full Text] [Related]
20. Clinical role of Bcl-2, Bax, or p53 overexpression in peripheral T-cell lymphomas.
Jung JT; Kim DH; Kwak EK; Kim JG; Park TI; Sohn SK; Do YR; Kwon KY; Song HS; Park EH; Lee KB
Ann Hematol; 2006 Sep; 85(9):575-81. PubMed ID: 16673127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]